Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zeo ScientifiX ( (ZEOX) ) has issued an update.
Effective January 23, 2026, Zeo ScientifiX appointed Dr. John D. Kisiday as Chief Science Officer, bringing nearly three decades of experience in tissue engineering, regenerative medicine and orthobiologics, including cell-, biomaterial- and drug-based therapies, as well as a long academic track record at Colorado State University and recent consulting and adjunct professorship roles. Under an at-will employment agreement effective the same date, he will receive a base salary of $175,000 and a stock grant of 50,000 shares vesting over two years, with additional compensation possible if he introduces commercially viable products or business opportunities beyond the company’s current scope, alongside severance protections tied to termination without cause or for good reason and standard confidentiality, non-compete and non-solicitation covenants.
More about Zeo ScientifiX
Average Trading Volume: 10,766
Technical Sentiment Signal: Strong Buy
Current Market Cap: $17.95M
For an in-depth examination of ZEOX stock, go to TipRanks’ Overview page.